Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cholesterol/Lipid Disorders
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cholesterol/Lipid Disorders
    TopAbstracts in Cholesterol/Lipid Disorders 10/02/2008 - (DGNews)
    FDA Analysis Shows Statins Do Not Increase the Risk of ALS - (DGNews)
    TopAbstracts in Cholesterol/Lipid Disorders 09/18/2008 - (DGNews)
    Add-On Cholesterol Therapy Using Ezetimibe May Be More Effective Than Alternative Therapies Due to Pharmacological Synergy: Presented at ACCP - (DGDispatch)
    Statins Lower Risk of Recurrent Stroke in Both Elderly, Younger Patients - (DGNews)

    News archive

     Recent webcasts/CME - Cholesterol/Lipid Disorders
      Residual CV Risk and Future Treatment Strategies
      Vascular Protection and CB1 Blockade: Evolving Data
      Cardiometabolic Risk and Risk Management
      Understanding Metabolic Syndrome: Knowing the Risks
      Evidence-based Review of Lipid Treatment in 2008

      Webcasts/CME archive

       Recent cases - Cholesterol/Lipid Disorders
        Acute Myocardial Infarction in an 18 Year Old South Indian Girl with Familial Hypercholesterolemia: A Case Report
        Eruptive Xanthomas and Acute Pancreatitis in a Patient with Hypertriglyceridemia
        Abetalipoproteinemia: Two Case Reports and a Literature Review
        Familial Hypercholesterolemia with Coarctation of Aorta
        Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication

        Cases archive
          




        my personal edition > cholesterol/lipid disorders > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Ispaghula Husk Nearly As Effective As Simvastatin For Hyperlipidemia

        A DGReview of :"A Comparative Evaluation of Ispaghula Husk (Dietary Fiber) and Simvastatin in Hyperlipidemic Indian Patients"
        Indian Heart Journal

        12/24/2002
        By James Adams


        Ispaghula husk (psyllium) is nearly as effective as simvastatin for improving the lipid profile of hyperlipidemic patients.

        It is also much cheaper and has fewer side effects than does simvastatin, report investigators from the Government Medical College in Amritsar, India.

        The investigators randomized 60 hyperlipidemic patients into two groups of 30. One group received 3.5 grams of ispaghula husk twice a day and the second group received 20 milligrams of simvastatin each day. Treatment continued for 12 weeks, and lipid profiles were evaluated at 0, 4, 8 and 12 weeks.

        Results showed that total cholesterol decreased by 15.8 percent and low-density lipoprotein (LDL) cholesterol decreased by 22.97 percent among patients taking ispaghula husk.

        Triglycerides decreased by 20.89 percent and high-density lipoprotein (HDL) cholesterol increased by 10.69 percent in these patients.

        Among patients taking simvastatin, total cholesterol decreased by 24.15 percent, LDL cholesterol decreased by 36.08 percent, triglycerides decreased by 20.47 percent and HDL cholesterol increased by 11.4 percent.

        Mild gastrointestinal disturbances were reported by 23.34 percent of the ispaghula husk patients. Feelings of cold in the joints and diuresis were each reported by 6.67 percent of ispaghula husk patients.

        In the simvastatin group, 26.66 percent reported mild gastrointestinal disturbance, 16.67 percent reported mild myalgia and 6.67 percent experienced insomnia.

        Ispaghula husk is an effective and well-tolerated dietary adjunct for patients with hyperlipidemia and should be considered before initiating conventional drug therapy, the investigators conclude.

        They point out that larger and longer studies are required to determine the long-term benefits of ispaghula husk.
        Indian Heart Journal 2002; 54(5). "A Comparative Evaluation of Ispaghula Husk (Dietary Fiber) and Simvastatin in Hyperlipidemic Indian Patients"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send